Bourgoin Insights Group, LLC Launches to Set a New Standard in Biosimilars Market Insights

·       Maine-Based Company Sets Sights on Becoming the Leading Platform for U.S. Biosimilars Insights

·       Introducing All Things Biosimilar: The First Dedicated U.S. Biosimilars Market Intelligence Platform

·       Flexible Subscription Model Offers Tailored Solutions for Businesses of All Sizes .

Maine, USA – January 22, 2025 – Bourgoin Insights Group, LLC (BIG) has officially launched as a pioneering information services company dedicated to solving business challenges in the U.S. biosimilars market. At the core of its offerings is All Things Biosimilar, a first-of-its-kind platform providing comprehensive insights, actionable analysis, and expert opinions tailored to the fast-growing and competitive U.S. biosimilars industry.

As the only singularly focused biosimilars market intelligence platform, All Things Biosimilar delivers unparalleled insights through a flexible, tiered subscription model. This approach allows clients to select the level of access they need, combining deep expertise with a user-centric design to provide organizations with up-to-date information to support sustainable and strategic decision-making and help maintain a competitive edge in this complex market.

“After more than 15 years in the U.S. biosimilars market, I’ve seen firsthand the urgent need for comprehensive, up-to-date information services tailored to this dynamic industry,” said Andrew Bourgoin, Founder of Bourgoin Insights Group. “With BIG and initiatives like All Things Biosimilar, my goal is to build the leading platform for biosimilars insights and support the critical stakeholders shaping the future of this market.”

Headquartered in Maine, BIG not only aims to redefine biosimilars market intelligence but also plans to expand its versatile capabilities to support local businesses. This strategic vision positions BIG as a leader in innovative business solutions, driving impact far beyond the biosimilars space.

About Bourgoin Insights Group, LLC
Bourgoin Insights Group, LLC (BIG) is a solutions-oriented information services company based in Maine. BIG specializes in providing actionable insights, data-driven strategies, and market intelligence to help businesses navigate complex challenges. Its flagship platform, All Things Biosimilar, is the first and only dedicated U.S. biosimilars market intelligence solution, delivering unparalleled insights through a flexible subscription model and consulting services. While BIG’s primary focus is on biosimilars, its adaptable expertise allows it to support organizations across diverse industries and markets.

For more information, visit: www.bourgoininsightsgroup.com

Contact
Andrew Bourgoin
Founder
Admin@bourgoininsightsgroup.com